/ /

  • linkedin
  • Increase Font
  • Sharebar

    Researchers, scientists flock to East Coast for ARVO 2017

    ‘Global Connections’ theme emphasizes scientific teamwork for advancing vision science



    Keynotes and Lectures

    ARVO Alcon Keynote Session

    Sunday, 12 to 1:15 p.m.

    The 2017 Opening Keynote speaker is Mary-Claire King, PhD, professor of medical genetics at the University of Washington. Dr. King has made numerous seminal contributions to genetics. During her doctoral training she found humans and chimpanzees share 99% of their genome. She was the first to identify and name BRCA1, an inheritable gene associated with breast cancer. Her lab also is pursuing de novo mutations that may cause schizophrenia and identifying the genetic causes of severe inherited disorders in Middle Eastern families. Dr. King’s presentation will be the first ARVO Opening Keynote delivered by a woman.

    The 2017 Basic/Clinical Lecture

    Sunday, 5:15 to 7:15 p.m.

    The topic for this event is “Improving Global Eye Health: Beating the Odds for Neglected and Emerging Diseases Around the World.” This symposium will bring together diverse experts to describe the impact of key eye diseases on human health in networks of connected communities from local to global levels.


    Beckman-Argyros Award in Vision Research Lecture

    Sunday, 5:30 to 6:30 p.m.

    This lecture will be delivered by Jeremy Nathans, MD, PhD, of Johns Hopkins University School of Medicine.


    Proctor Award and Lecture

    Monday, 5:45 to 6:30 p.m.

    This will be given by Gustavo D. Aguirre, VMD, PhD, FARVO, of the University of Pennsylvania. His topic will be “From the Cage to the Bedside--Concepts and Strategies in Retinal Gene Therapy.” His work has shown that gene therapy can arrest advanced photoreceptor and vision loss, dramatically expanding the therapeutic window to late stages of disease.

    Mildred Weisenfeld Award and Lecture

    Monday, 6:45-7:30 p.m.

    Johanna Seddon, MD, MS, FARVO, of Tufts University School of Medicine and Tufts Medical Center, will speak on the topic of “Macular Degeneration Epidemiology: Nature-Nurture, Lifestyle Factors, Genetic Risk and Gene-Environment Interactions.” Dr. Seddon is a pioneer in ophthalmic epidemiology, particularly the study of nutritional, environmental and genetic risk factors for AMD.

    ARVO/Champalimaud Vision Award Lecture

    Tuesday, 5:45 to 7 p.m.

    The work of the four awardees, John Flanagan, Christine Holt, Carol Mason, and Carla Shatz, has shined light on the connection between the two fundamental organs responsible for vision -- the eye and the brain -- and their work has greatly advanced the understanding of the visual system. Mason and Shatz will speak at this event.

    Cogan Award and Lecture

    Wednesday, 5:45 to 6:30 p.m.

    Andrew Huberman, PhD, of Stanford University School of Medicine, will speak on the topic of “Visual Restoration and Function: From Genetics to Virtual Reality.” Dr. Huberman has more than 15 years of experience studying the development, function, and repair of mammalian visual circuits. He has made fundamental discoveries regarding the mechanisms of binocular circuit development, and pioneered the use of genetic and viral tools for labeling and probing specific retinal cells and their associated brain circuits. He is also forging paths in retinal disease research by bringing modern genetic tools to the study of glaucoma and optic nerve repair.

    Friedenwald Award and Lecture

    Wednesday, 6:45 to 7:30 p.m.

    Paul Kaufman, MD, University of Wisconsin, will speak on the topic of “Presbyopia and Glaucoma -- The Missing Link?” Dr. Kaufman has had a long career of performing pioneering work in several areas of ophthalmic research. Much of our current understanding of the aqueous humor outflow system in the eye have been the direct result of his work.

    Closing Keynote Session

    Thursday, 1:30 to 3:15 p.m.

    The topic of this session will be “What’s Next in the Investigation of Genetics of Age-Related Macular Degeneration?” A panel of experts will focus on the next set of potential investigations to further our understanding of the pathogenesis of AMD based upon current knowledge of the genetics of the disease.


    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results